A different STING antagonist that acts by modulating the interaction of STING with stromal interaction molecule 1 (STIM1), thereby blocking its trafficking from ER to Golgi, inhibited the progression of lupus, another photosensitive autoimmune disease, in human patients. This evidence concerns the gene STIM1 and systemic lupus erythematosus.